Literature DB >> 3989566

Studies on a cerebellar 50,000-dalton protein associated with cerebellar hypoplasia in jaundiced Gunn rats: its identity with glial fibrillary acidic protein as evidenced by the improved immunoblotting method.

S Aono, H Sato, R Semba, S Kashiwamata, L F Eng.   

Abstract

On the basis of our previous findings that a 50,000-dalton protein (GR-50) shows a marked increase in the hypoplastic cerebellum of jaundiced homozygous Gunn rats and its electrophoretic behavior is similar to that of glial fibrillary acidic protein (GFAP), we tried to identify GR-50 as GFAP by two-dimensional electrophoresis of rat cerebellar membrane proteins using an improved immunoblotting method. In this method a blot immunostained for a specific antigen was also visualized for other proteins, thereby enabling us to determine the location of the antigen on the blot more precisely. With the methodology it was found that GFAP antigen occupied exactly the same position as GR-50 on the blot, suggesting strongly the identity of both proteins. Immunohistochemical studies revealed that in the cerebellum of homozygotes compared with that of heterozygotes GFAP antigen was greatly increased and that it was especially rich in the homozygous rat cerebellar lobules with a high degree of hypoplasia. Further, it was shown that not only the fibers of the Bergmann glial cells but also their somata were intensely immunostained in the affected lobules. A 47,000-dalton protein (SG-47), which has been reported to be increased in staggerer mutant mice with cerebellar hypoplasia, also immunoreacted with the antiserum to GFAP.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3989566     DOI: 10.1111/j.1471-4159.1985.tb07183.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  1 in total

1.  Absence of erythrocyte arginase protein in Japanese patients with hyperargininemia.

Authors:  C Hayakawa; S Aono; H Keino; N Mizutani; K Watanabe; M Ikemoto; M Totani; T Murachi; S Kashiwamata
Journal:  Eur J Pediatr       Date:  1991-09       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.